» Articles » PMID: 33148544

Gender-specific Aspects of Epidemiology, Molecular Genetics and Outcome: Lung Cancer

Overview
Journal ESMO Open
Publisher Elsevier
Specialty Oncology
Date 2020 Nov 5
PMID 33148544
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer remains the leading cause of cancer-related deaths worldwide in women and men. In incidence, lung cancer ranks second, surpassed by breast cancer in women and prostate cancer in men. However, the historical differences in mortality and incidence rate between both sexes have changed in the last years. In the last decades, we have also witnessed an increased number of lung cancer in female never-smokers. These disparities have grown our interest in studying the impact of the gender and sex in the presentation of lung cancer. The aetiology is yet to be fully elucidated, but the data are clear so far: there is a growing divide between lung cancer presentation in women and men that will change our management and study of lung cancer. This article aims to review the sex and gender differences in lung cancer.

Citing Articles

Identifying Sex Differences in Lung Adenocarcinoma Using Multi-Omics Integrative Protein Signaling Networks.

Chen C, Saha E, Fischer J, Ben Guebila M, Fanfani V, Shutta K bioRxiv. 2025; .

PMID: 39975108 PMC: 11838606. DOI: 10.1101/2025.02.03.636354.


Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020s.

Mosleh B, Sarova P, Zehetmayer S, Oberndorfer F, Widder J, Prosch H Heliyon. 2025; 11(2):e42089.

PMID: 39925357 PMC: 11804590. DOI: 10.1016/j.heliyon.2025.e42089.


Metagenomic and Transcriptomic Analysis Reveals Crosstalk Between Intratumor Mycobiome and Hosts in Early-Stage Nonsmoking Lung Adenocarcinoma Patients.

Sun Y, Gan Z, Liu S, Zhang S, Zhong W, Liu J Thorac Cancer. 2025; 16(2):e15527.

PMID: 39853685 PMC: 11756924. DOI: 10.1111/1759-7714.15527.


Sex-based differences in CEACAM5 expression in lung cancer.

Woodard G, Kane E, Todorovic N, Prince S, Dacic S, Chen L Transl Cancer Res. 2024; 13(11):6394-6402.

PMID: 39697744 PMC: 11651760. DOI: 10.21037/tcr-24-983.


The current state and trends of immunotherapy research in lung cancer: a review and bibliometric analysis.

Zheng Y, Chen L, Liu X, Li R, Lei H, Chen G Front Oncol. 2024; 14:1428307.

PMID: 39588305 PMC: 11586257. DOI: 10.3389/fonc.2024.1428307.


References
1.
Cufari M, Proli C, De Sousa P, Raubenheimer H, Al Sahaf M, Chavan H . Increasing frequency of non-smoking lung cancer: Presentation of patients with early disease to a tertiary institution in the UK. Eur J Cancer. 2017; 84:55-59. DOI: 10.1016/j.ejca.2017.06.031. View

2.
Shriver S, Bourdeau H, Gubish C, Tirpak D, Davis A, Luketich J . Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst. 2000; 92(1):24-33. DOI: 10.1093/jnci/92.1.24. View

3.
Seaton M, Kyerematen G, Morgan M, Jeszenka E, Vesell E . Nicotine metabolism in stumptailed macaques, Macaca arctoides. Drug Metab Dispos. 1991; 19(5):946-54. View

4.
Drope J, Liber A, Cahn Z, Stoklosa M, Kennedy R, Douglas C . Who's still smoking? Disparities in adult cigarette smoking prevalence in the United States. CA Cancer J Clin. 2018; 68(2):106-115. DOI: 10.3322/caac.21444. View

5.
Huisman M, Kunst A, Mackenbach J . Inequalities in the prevalence of smoking in the European Union: comparing education and income. Prev Med. 2005; 40(6):756-64. DOI: 10.1016/j.ypmed.2004.09.022. View